Cohen & Co (COHN) Company Report

Cohen & Company Capital Markets, a division of Cohen & Company Inc. (COHN), announced the appointment of Rahul Jasuja as Head of Energy and Energy Transition and the opening of its Houston office on January 12, 2026.
The Houston office will serve as the firm's hub for energy and energy transition advisory services, focusing on four core verticals: firm and scalable energy systems, critical energy supply chains, energy transition fuels and technologies, and traditional energy and portfolio evolution.
This expansion is based on a sector thesis that views energy transition as an expansion of the global energy system, with Houston as a critical center for capital and expertise.
In 2025, Cohen & Company Capital Markets nearly doubled deal flow and closed $44 billion in transactions.

Jan 12, 2026, 1:00 PM

Press Release

Cohen & Co Inc. Announces Special Cash Dividend

COHN

Dividends

Financial Performance

Cohen & Company Inc. announced a special cash dividend of $2.00 per share.
The dividend is payable on January 22, 2026, to stockholders of record as of January 7, 2026.
CEO Lester Brafman stated the dividend reflects the company's recent strong operating performance and commitment to returning value to stockholders.

Dec 22, 2025, 1:24 PM

8-K

Robex Resources Amends Arrangement Agreement with Predictive Discovery; Shareholder Meeting Postponed

COHN

M&A

Takeover Bid

Proxy Vote Outcomes

Robex Resources Inc. and Predictive Discovery Limited have amended their arrangement agreement, with Robex Shareholders now set to receive 7.862 Predictive Shares for each Robex Share, resulting in Robex Shareholders owning 46.5% of the combined company.
The Robex Board unanimously recommends that shareholders vote FOR the amended arrangement, with major shareholders representing approximately 23.8% of outstanding Robex Shares having already agreed to vote in favor.
The special meeting of shareholders to consider the arrangement has been postponed to December 30, 2025, at 8:00 a.m. (Eastern Time), with a revised proxy deadline of December 29, 2025, at 5:00 p.m. (Eastern Time).
The merger is expected to create one of West Africa’s leading gold producers by combining two large, low-cost projects, and is anticipated to be accretive to shareholders over the medium term.

Dec 11, 2025, 5:20 AM

Press Release

Cohen & Company Reports Third Quarter 2025 Financial Results

COHN

Earnings

Dividends

Guidance Update

Cohen & Company Inc. reported revenue of $84.2 million for the third quarter ended September 30, 2025, an increase from $59.9 million in the prior quarter and $31.7 million in the prior year quarter.
Net income attributable to Cohen & Company Inc. was $4.6 million, or $2.58 per diluted share, for Q3 2025.
Adjusted pre-tax income for the quarter was $16.4 million, or $2.71 per diluted share.
The company's Board of Directors declared a quarterly dividend of $0.25 per share, payable on December 3, 2025.
The strong Q3 2025 results were primarily driven by $228.0 million in new issue and advisory revenue from the Capital Markets division, partially offset by negative principal transactions revenue of $159.3 million. The company expects to generate more than $50 million in revenue in Q4 2025 and more than $220 million for the full year 2025.

Nov 4, 2025, 1:08 PM

8-K

Cohen & Company Reports Third Quarter 2025 Financial Results

COHN

Earnings

Dividends

Guidance Update

Cohen & Company Inc. reported revenue of $84.2 million for the third quarter ended September 30, 2025, an increase from $59.9 million in the prior quarter and $31.7 million in the prior year quarter.
Net income attributable to Cohen & Company Inc. was $4.6 million, or $2.58 per diluted share, for the three months ended September 30, 2025.
The company's Board of Directors declared a quarterly dividend of $0.25 per share, payable on December 3, 2025, to stockholders of record as of November 19, 2025.
Third quarter results were primarily driven by strong performance from the Capital Markets division, with Cohen & Company Capital Markets (CCM) generating $228.0 million in advisory revenue, and net trading revenue increasing 26% from the previous quarter.
Cohen & Company expects to generate more than $50 million in revenue for the fourth quarter and over $220 million for the full year 2025.

Nov 4, 2025, 1:00 PM

Press Release

Xanadu Quantum Technologies to Go Public via Business Combination with Crane Harbor Acquisition Corp.

COHN

M&A

New Projects/Investments

Xanadu Quantum Technologies, Inc. and Crane Harbor Acquisition Corp. have entered into a definitive business combination agreement, which is expected to result in Xanadu becoming the first and only publicly traded pure-play photonic quantum computing company.
The combined company is projected to have a pro forma enterprise value of approximately US$3.1 billion and a pro forma market capitalization of approximately US$3.6 billion.
The transaction is expected to generate approximately US$500 million in gross proceeds, including US$275 million from a fully committed common equity PIPE, with over 90% of the PIPE capital coming from new strategic and institutional investors.
Xanadu has achieved significant milestones, including producing the first networked, modular, and scalable quantum computer (Aurora system) in early 2025 and demonstrating quantum supremacy in 2022. Its PennyLane software is also the #1 quantum programming software with 47% usage among quantum programmers.

Nov 3, 2025, 12:00 PM

Press Release

HOPE Therapeutics Acquires Cohen & Associates, LLC and Appoints Dr. Rebecca Cohen as Medical Director

COHN

M&A

Management Change

New Projects/Investments

HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc., has acquired a strategic interest in Cohen and Associates, LLC, incorporating it into the HOPE Network.
Dr. Rebecca Cohen, founder of Cohen and Associates, LLC and an expert in interventional psychiatry and Transcranial Magnetic Stimulation (TMS), has been appointed as Medical Director for HOPE's Florida locations.
The acquisition is expected to be accretive to HOPE Therapeutics revenue and EBITDA, with immediate expansion planned in Western Florida and Palm Beach.

Oct 20, 2025, 12:03 PM

Press Release

Critical Metals Corp. Secures $35 Million PIPE Financing

COHN

New Projects/Investments

Critical Metals Corp. (CRML) announced on October 6, 2025, a Private Investment in Public Equity (PIPE) transaction to raise $35,000,000 in gross proceeds from a fundamental institutional investor.
The company intends to use the net proceeds to help fund the development of its 4.7 billion metric ton rare earth deposit, Tanbreez, in Greenland.
Under the terms, Critical Metals Corp. will issue 5 million ordinary shares and warrants to purchase 10 million ordinary shares at a strike price of $7.00 per share, with a 6-year expiration.

Oct 6, 2025, 12:03 PM

Press Release

Predictive Discovery and Robex Announce Merger of Equals

COHN

M&A

New Projects/Investments

Takeover Bid

Predictive Discovery Limited (PDI) and Robex Resources Inc. (Robex) have entered into a definitive agreement for a merger of equals, with PDI acquiring all outstanding Robex Shares.
Robex shareholders will receive 8.667 PDI Shares for each Robex Share, leading to existing PDI shareholders owning approximately 51% and former Robex shareholders approximately 49% of the combined company on a fully diluted in-the-money basis.
The combined company is projected to exceed 400kozpa Au production by 2029, with combined Mineral Resources of approximately 9.5Moz Au and Ore Reserves of approximately 4.5Moz Au.
With an implied market capitalization of A$2,350 million (C$2,168 million), the transaction aims to create West Africa's next mid-tier gold producer and is expected to close in December 2025 or early 2026.